StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) stock

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-3.04%)

Close on Nov 17, 2026Market cap $1.60MP/E –Yield –

Vivos Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vivos Therapeutics's price to sales ratio was 0.1× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.1× to 4.6×, with a median of 0.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−0.9
2025Dec 31, 20251.0×−0.4
2024Dec 31, 20241.4×+0.4
2023Dec 29, 20231.0×+0.5
2022Dec 30, 20220.6×−2.7
2021Dec 31, 20213.3×−3.2
2020Dec 31, 20206.5×–

More Vivos Therapeutics figures

See a number that looks wrong?